ERK/MAPK-dependent PI3K/Akt phosphorylation through VEGFR-1 after VEGF stimulation in activated hepatic stellate cells

Hepatology Research

Volumn 26, Issue 3, 2003, Pages 232-236

  Takahashi, Masanobu ^a   Matsui, Atsushi ^a   Inao, Mie ^a   Mochida, Satoshi ^a   Fujiwara, Kenji ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

MAPK; PI3K; PKC; Stellate cells; VEGF; VEGFR 1

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE C INHIBITOR; VASCULOTROPIN RECEPTOR 1;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; CULTURE MEDIUM; CULTURE VESSEL; DNA SYNTHESIS; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FETAL CALF SERUM; IN VITRO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; RAT; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; STELLATE CELL; WESTERN BLOTTING;

EID: 0042167595     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6346(03)00112-8     Document Type: Article

References (24)

1. Ferrara N, Henzel WJ. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 1989;161:851-8.
2. Yamane A, Seetharam L, Yamaguchi S, Gotoh N, Takahashi T, Neufeld G, et al. A new communication system between hepatocytes and sinusoidal endothelial cells in liver through vascular endothelial growth factor and Flt tyrosine kinase receptor family (Flt-1 and KDR/Flk-1). Oncogene 1994;9:2683-90.
3. Shibuya M. Role of VEGF-flt receptor system in normal and tumor angiogenesis. Adv Cancer Res 1995;67:281-316.
4. Shibuya M, Yamaguchi S, Yamane A, Ikeda T, Tojo A, Matsushime H, et al. Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family. Oncogene 1990;5:519-24.
5. Terman BI, Carrion ME, Kovacs E, Rasmussen BA, Eddy RL, Shows TB. Identification of a new endothelial cell growth factor receptor tyrosine kinase. Oncogene 1991;6:1677-83.
6. Galland F, Karamysheva A, Mattei MG, Rosnet O, Marchetto S, Birnbaum D. Chromosomal localization of FLT4, a novel receptor-type tyrosine kinase gene. Genomics 1992:13:475-8.
7. Ishikawa K, Mochida S, Mashiba S, Inao M, Matsui A, Ikeda H, et al. Expressions of vascular endothelial growth factor in nonparenchymal as well as parenchymal cells in rat liver after necrosis. Biochem Biophys Res Commun 1999;254:587-93.
8. Joukov V, Pajusola K, Kaipainen A, Chilov D, Lahtinen I, Kukk E, et al. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 1996;15:290-8.
9. Takahashi T, Ueno H, Sibuya M. VEGF activates protein kinase C-dependent, but Ras-independent Raf-MEK-MAP kinase pathway for DNA synthesis in primary endothelial cells. Oncogene 1999;18:2221-30.
10. Hiratsuka S, Minowa O, Kuno J, Noda T, Shibuya M. Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice. Proc Natl Acad Sci USA 1998;95:9349-54.
11. Mashiba S, Mochida S, Ishikawa K, Inao M, Matsui A, Ohno A, et al. Inhibition of hepatic stellate cell contraction during activation in vitro by vascular endothelial growth factor in association with upregulation of FLT tyrosine kinase receptor family, FLT-1. Biochem Biophys Res Commun 1999;258:674-8.
12. Knook DL, Seffelaar AM, de Leeuw AM. Fat-storing cells of the rat liver: their isolation and purification. Exp Cell Res 1982;139:468-71.
13. Inao M, Mochida S, Ikeda H, Awaya A, Fujiwara K. Effects of neurotropic pyrimidine heterocyclic compound, MS-430, on cultured hepatic parenchymal and stellate cells. Life Sci 1997;61:273-82.
14. Ballardini G, Fallani M, Biagini G, Bianchi FB, Pisi E. Desmin and actin in the identification of Ito cells and in monitoring their evolution to myofibroblasts in experimental liver fibrosis. Virchows Arch B Cell Pathol 1988;56:45-9.
15. Tuullec D, Pianetti P, Coste H, Bellevengue P, Grand-Perret T, Ajakane M, et al. The bisindolylmaleimide GF 109203 X is a potent and selective inhibitor of protein kinase C. J Biol Chem 1991;266:15771-81.
16. Dudley DT, Pang L, Decker SJ, Bridges AJ, Saltiel AR. A synthetic inhibitor of mitogen-activated protein kinase cascade. Proc Natl Acad Sci USA 1995;92:7686-9.
17. Lam K, Carpenter CL, Ruderman NB, Friej JC, Kelly KL. The phospbatidylinositol 3-kinase serine kinase phasphorylates IRS-1: stimulation by insulin and inhibition by Wortmannin. J Biol Chem 1994;269:20649-52.
18. Friedman SL. Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis: mechanisms and treatment strategies. N Engl J Med 1993;328:1828-35.
19. Schramek H, Sorokin A, Watson RD, Dunn MJ. ET-1 and PDGF BB induce MEK mRNA and protein expression in mesangial cells. J Cardiovas Pharmacol 1995;26:S95-9.
20. Kazlauskas A, Cooper JA. Phosphorylation of the PDGF receptor beta subunit creates a tight binding site for phosphatidylinositol 3 kinase. EMBO J 1990;9:3279-86.
21. Igarashi K, Isohara T, Kato T, Shigeta K, Yamano T, Uno I, Tyrosine 1213 of Flt-1 is a major binding site of Nck and SHP-2. Biochem Biophys Res Commun 1998;246:95-9.
22. Moelling K, Schad K, Bosse M, Zimmermann S, Schweneker M. Regulation of Raf-Akt Cross-talk. J Biol Chem 2002;277:31099-106.
23. Ankoma-Sey V, Matli M, Chang KB, Lalazar A, Donner DB, Wong L, et al. Coordinated induction of VEGF receptors in mesenchymal cell types during rat hepatic wound healing. Oncogene 1998;17:115-21.
24. Radisavljevic Z, Avraham H, Avraham S. Vascular endothelial growth factor up-regulates ICAM-1 expression via the phosphatidylinositol 3 OH-kinase/AKT/Nitric oxide pathway and modulates migration of brain microvascular endothelial cells. J Biol Chem 2000;275:20770-4.